Elixir Titelbild

Elixir

In the Valley at the End of Time

Reinhören
0,00 € - kostenlos hören
Prime Logo Bist du Amazon Prime-Mitglied?
Audible 60 Tage kostenlos testen
Aktiviere das kostenlose Probeabo mit der Option, monatlich flexibel zu pausieren oder zu kündigen.
Nach dem Probemonat bekommst du eine vielfältige Auswahl an Hörbüchern, Kinderhörspielen und Original Podcasts für 9,95 € pro Monat.
Wähle monatlich einen Titel aus dem Gesamtkatalog und behalte ihn.

Elixir

Von: Kapka Kassabova
Gesprochen von: Natalie Pela
0,00 € - kostenlos hören

9,95 € pro Monat nach 30 Tagen. Monatlich kündbar.

Für 35,95 € kaufen

Für 35,95 € kaufen

Über diesen Titel

Brought to you by Penguin.

Set in the valley of the Mesta, one of the oldest inhabited river valleys in Europe and a nexus for wild plant gatherers, Elixir is an unforgettable exploration of the deep connections between people, plants and place.

Over several seasons, Kassabova spends time with the people of this magical region. She meets women and men who work in a long lineage of foragers, healers and mystics. She learns about wild plants and the ancient practice of herbalism, and experiences a symbiotic system where nature and culture have blended for thousands of years. Through her captivating encounters we come to feel the devastating weight of the ecological and cultural disinheritance that the people of this valley have suffered. Yet, in her search for elixir, she also finds reasons for hope. The people of the valley are keepers of a rare knowledge, not only of mountain plants and their properties, but also of how to transform collective suffering into healing.

Immersive and enthralling, at its heart Elixir is a search for a cure to what ails us in the Anthropocene. It is an urgent call to rethink how we live - in relation to one another, to the Earth and to the cosmos.

©2023 Kapka Kassabova (P)2023 Penguin Audio
Anthropologie Reiseliteratur & Erläuterungen Wissenschaft

Kritikerstimmen

'Exceptional.' BBC Wildlife

'Dark and mysterious and beautiful.' Financial Times

Noch keine Rezensionen vorhanden